Using data from the ACTION ( A Coronary disease Trial Investigating Outcome with Nifedipine GITS ) study , we compared the impact on event-rates of an adjudication strategy based on systematic screening of all reported serious adverse events ( SAEs ) with a strategy based on investigator diagnoses .
